Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-02-12
2011-12-06
Kosar, Andrew D (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S469000, C549S470000, C514S469000, C514S489000
Reexamination Certificate
active
08071797
ABSTRACT:
Compounds having the formula I wherein R1, R2, R3, R4, R5and X are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
REFERENCES:
patent: 7265152 (2007-09-01), Saha et al.
patent: 2007/0224167 (2007-09-01), Emini et al.
patent: 2007/0231318 (2007-10-01), Saha et al.
patent: WO 2008/100867 (2008-08-01), None
patent: WO 2008/100867 (2008-08-01), None
Labadie Sharada Shenvi
Lin Clara Jeou Jen
Talamas Francisco Xavier
Weikert Robert James
Buckwalter Brian L.
Covington Raymond
Kosar Andrew D
Roche Palo Alto LLC
LandOfFree
Heterocyclic antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic antiviral compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4309409